Cargando…

Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

INTRODUCTION: Homologous recombination (HR) DNA repair is of clinical relevance in breast cancer. Three DNA-based homologous recombination deficiency (HRD) scores (HRD-loss of heterozygosity score (LOH), HRD-telomeric allelic imbalance score (TAI), and HRD-large-scale state transition score (LST)) h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timms, Kirsten M, Abkevich, Victor, Hughes, Elisha, Neff, Chris, Reid, Julia, Morris, Brian, Kalva, Saritha, Potter, Jennifer, Tran, Thanh V, Chen, Jian, Iliev, Diana, Sangale, Zaina, Tikishvili, Eliso, Perry, Michael, Zharkikh, Andrey, Gutin, Alexander, Lanchbury, Jerry S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308910/ https://www.ncbi.nlm.nih.gov/pubmed/25475740 http://dx.doi.org/10.1186/s13058-014-0475-x

Ejemplares similares

Computational Method for Estimating DNA Copy Numbers in Normal Samples, Cancer Cell Lines, and Solid Tumors Using Array Comparative Genomic Hybridization
por: Abkevich, Victor, et al.
Publicado: (2010)

PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
por: Atreya, Chloe E, et al.
Publicado: (2013)

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
por: Abkevich, V, et al.
Publicado: (2012)

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
por: Hodgson, Darren R., et al.
Publicado: (2018)

Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk
por: Judkins, Thaddeus, et al.
Publicado: (2015)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
por: Lotan, Tamara L., et al.
Publicado: (2021)

Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes
por: Lenz, Lauren, et al.
Publicado: (2023)

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer
por: Patel, Jai N., et al.
Publicado: (2018)

Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
por: Hughes, Elisha, et al.
Publicado: (2020)

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
por: Hughes, Elisha, et al.
Publicado: (2022)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model
por: Gallagher, Shannon, et al.
Publicado: (2021)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
por: Kalachand, Roshni D., et al.
Publicado: (2020)

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer
por: How, Jeffrey A., et al.
Publicado: (2021)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: Talhouet, Solene De, et al.
Publicado: (2020)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma
por: Bueno, Raphael, et al.
Publicado: (2015)

BRCA mutation in ovarian cancer: testing, implications and treatment considerations
por: Neff, Robert T., et al.
Publicado: (2017)

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling
por: Larsen, Martin J., et al.
Publicado: (2013)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes
por: Gruber, Joshua J., et al.
Publicado: (2022)

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
por: Mulligan, Anna Marie, et al.
Publicado: (2011)

Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer
por: Constantinidou, Anastasia, et al.
Publicado: (2022)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
por: Kuchenbaecker, Karoline B, et al.
Publicado: (2014)

Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients
por: Curtis, Jeffrey R., et al.
Publicado: (2020)

Comparative analysis of vertebrate EIF2AK2 (PKR) genes and assignment of the equine gene to ECA15q24–q25 and the bovine gene to BTA11q12–q15
por: Perelygin, Andrey A, et al.
Publicado: (2006)

Classification of genetic variants in genes associated with Lynch syndrome using a clinical history weighting algorithm
por: Morris, Brian, et al.
Publicado: (2016)

Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic Testing
por: Hughes, Elisha, et al.
Publicado: (2021)

Analysis of Vaccinia Virus−Host Protein−Protein Interactions: Validations of Yeast Two-Hybrid Screenings
por: Zhang, Leiliang, et al.
Publicado: (2009)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Recurrent BRCA1 Mutation, but no BRCA2 Mutation, in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing
por: Vu, Hoang Anh, et al.
Publicado: (2020)

Assessment of Blood Microcirculation Changes after COVID-19 Using Wearable Laser Doppler Flowmetry
por: Zharkikh, Elena V., et al.
Publicado: (2023)

AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia
por: Virts, Elizabeth L., et al.
Publicado: (2015)

Prevalence of smear positive pulmonary tuberculosis among outpatients presenting with cough of any duration in Shashogo Woreda, Southern Ethiopia
por: Eliso, Endale, et al.
Publicado: (2015)

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status
por: Prat, Aleix, et al.
Publicado: (2014)

A High Quality Draft Consensus Sequence of the Genome of a Heterozygous Grapevine Variety
por: Velasco, Riccardo, et al.
Publicado: (2007)

Molecular evolution
por: Ratner, Vadim A, et al.
Publicado: (1996)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nsldpje1t6m6piaeoh8lpuf70q